Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

Entropion Clinical Trial

Official title:

Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05854420
• Other study ID #: Modified ALR
• Status: Completed
• Phase: N/A
• Start date: May 1, 2018
• Est. completion date: March 15, 2021

Study information

• Verified date: May 2023
• Source: Al-Azhar University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to assess the combination of anterior lamellar recession (ALR) with blepharoplasty, suprasternal fixation, and internal eyelash bulb extirpation of aberrant lashes posteriorly located in patients with any grade of upper eyelid trachomatous cicatricial entropion

Recruitment information / eligibility

• Status: Completed
• Enrollment: 68
• Est. completion date: March 15, 2021
• Est. primary completion date: March 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 45 Years to 60 Years

Eligibility

Inclusion Criteria:

• All patients presented with upper lid trachomatous cicatricial entropion associated with rubbing lashes.

• Patients having a history of argon laser ablation, electrolysis, epilation, or past unsuccessful surgery were also included

Exclusion Criteria:

• Patients with a follow-up period of fewer than 12 months.

• Patients with very severe UCE and required posterior lamellar grafts.

• Patients with etiology other than trachoma.

• Patients with dysplastic lashes without entropion were excluded

Related Conditions & MeSH terms

• Entropion

Intervention

Procedure:
• Modified anterior Lamellar Recession
ALR is one of the procedures used to treat cicatricial entropion and trichiasis. Few studies present the effect of modifications to this procedure in trachomatous entropion and trichiasis. Because trachoma is common in our country, there is a probability that the number of surgeries for TT will rise.

Locations

Country	Name	City	State
Egypt	Ehab tharwat	Damieta	New Damietta

Sponsors (1)

Lead Sponsor	Collaborator
Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success rate	The cases will be considered succeed if there is no recurrence of the entropion	3 months post operative
Primary	Success rate	The cases will be considered succeed if there is no recurrence of the entropion	6 months post operative
Primary	Success rate	The cases will be considered succeed if there is no recurrence of the entropion	9 months post operative
Primary	Success rate	The cases will be considered succeed if there is no recurrence of the entropion	12 months post operative